samedan logo
 
 
spacer
home > pmps > autumn 2019 > a vision of full integration
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Vision of Full Integration





Serialisation is an increasingly hot topic in the pharmaceutical industry all over the world. Track and trace technologies have been developed over time to increase drug safety. Some sector experts believe these will be far more efficient when applied directly to primary packaging, allowing tracking to start tracking from the vial production and to trace the information alongside the whole supply chain – from factory to end user. Besides the industry, track and trace technologies could also be important – in a patient-centred approach – for the final user, who would be able to directly access information about the drug they are going to use. For that, it is key for pharma packaging producers to investigate a comprehensive approach and test several technologies aimed at developing a digital-ready primary packaging.

The pharma industry is destined to change radically in the next decade: as international consultancy giant McKinsey stated, several drivers will transform the industry, making it considerably different from the one we currently know. First of all, modern drugs will reach many more patients than today thanks to the emergence of a new middle-class in developing countries, allowing about 1 billion new patients to consume state-of-theart medications. To serve those who cannot afford medicines, innovative private-public partnerships will create new models, and new, unconventional channels will be put in place to overcome poor infrastructure and reach patients in remote places. In developed markets, the vast majority of medical needs will be addressed with generic drugs produced and distributed at scale and with great efficiency. Alongside these drugs, integrated solutions that combine diagnostics, devices, and drugs will create new businesses. Distribution channels and patient services will also further emerge and expand, especially for eldercare and special chronic diseases, as well as a broad range of new players in home and hospital care delivery, services, and nursing. Moreover, the number of partners and handover points will significantly rise.

 

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


After his first experience as a project manager, Federico Piutti specialised in innovation, working with important consultancy firms and developing innovation projects for national and international groups. For over 10 years, he’s been managing the development of projects and collaborations with research centres, startups, universities, and other players in the innovation environment, both in Italy and abroad. Federico is also in charge of Bormioli Pharma’s open innovation initiatives, part of the corporate programme Bormioli Pharma Invents.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Qatar Airways Cargo and ECS Group celebrate one year of serving Lyon

Since its first flight on 17SEP20, the leading international cargo airline, together with ECS Group, the world’s largest integrated GSSA, has flown more than 5 million kilos out of Lyon, France
More info >>

White Papers

Advantages of Quantitative NMR for the Determination of Relative Response Factors

Novatia, LLC

Quantitative NMR (qNMR) is a technique that is being applied broadly and at an increasing rate in the field of pharmaceutical analysis (1). This white paper highlights the advantages of using qNMR to determine Relative Response Factors (RRFs) for pharmaceutical impurities detectable by HPLC. A single determination of RRFs using qNMR allows for simple and accurate quantitation of impurities which eliminates the need for preparation, qualification, and storage of reference standards. An example is presented here, which demonstrates quantitation of known impurities that have variable responses to UV-VIS detection, thereby providing a more accurate assessment of impurity levels than UV-VIS response alone.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement